Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Acta Pharmaciae Indonesia : Acta Pharm Indo
Turnip, Monika Maristella
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Evaluation of the physical properties of andaliman (Zanthoxylum acanthopodium DC) fruit extract tablets using polyvinylpyrrolidone as a binder agent Turnip, Monika Maristella; Sunarti, Sunarti; Nawangsari, Desy
Acta Pharmaciae Indonesia Vol 11 No 1 (2023): Acta Pharmaciae Indonesia : Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.api.2023.11.1.6900

Abstract

Background: Zanthoxylum acanthopodium DC, also known as andaliman, is a traditional herb utilized predominantly as a spice. It is rich in bioactive compounds such as alkaloids, flavonoids, tannins, saponins, and terpenoids, which exhibit analgesic activities. Objective: This study aims to develop a tablet formulation of andaliman fruit extract, employing polyvinyl pyrrolidone (PVP) K-30 as a binder, utilizing the wet granulation method. Method: The andaliman fruit was processed to extract its components using 96% ethanol. The extract, at a concentration of 100 mg, was then formulated into three different tablet formulations, varying in PVP K-30 concentration: F1 (1%), F2 (3%), and F3 (5%). These formulations were analyzed for granule characteristics and physical properties of the tablets. Results: Granule testing confirmed that all formulations met the requirements for quality granules. Among the formulations, F1 (1% PVP concentration) demonstrated superior physical properties: size uniformity of 1.22±0.00 cm, weight uniformity of 518.53±10.15 mg, friability of 0.45±0.01%, hardness of 6.34±0.05 kg, and disintegration time of 9.42±0.90 minutes. Conclusion: The tablet formulation of Andaliman fruit extract with 1% PVP K-30 exhibited the most favorable physical properties, suggesting its potential viability for further development and testing. This study lays the groundwork for exploring Andaliman fruit-based analgesic tablets.
Co-Authors Nawangsari, Desy Sunarti